NCT03794518View on ClinicalTrials.gov

Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF

PHASE3UnknownINTERVENTIONAL
Enrollment

648

Participants

Timeline

Start Date

March 31, 2019

Primary Completion Date

September 30, 2021

Study Completion Date

December 31, 2021

Conditions
Risk Reduction
Interventions
DRUG

Pioglitazone Plus dapaglifliozin

Pioglitazone Plus dapaglifliozin

DRUG

Placebo

(Beta blockers, ACEI, ARB, and aldosterone )

Trial Locations (1)

3050

Heart Hospital, Hamad Medical Coorporation, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY

NCT03794518 - Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF | Biotech Hunter | Biotech Hunter